Cipla Limited (LUX:CIPLA)
Luxembourg flag Luxembourg · Delayed Price · Currency is EUR · Price in USD
17.30
-0.10 (-0.57%)
At close: May 9, 2025
8.13%
Market Cap 13.00B
Revenue (ttm) 3.08B
Net Income (ttm) 570.90M
Shares Out n/a
EPS (ttm) 0.71
PE Ratio 22.78
Forward PE 23.83
Dividend 0.11 (0.63%)
Ex-Dividend Date Aug 1, 2024
Volume n/a
Average Volume n/a
Open n/a
Previous Close 17.40
Day's Range n/a
52-Week Range n/a
Beta n/a
RSI 53.74
Earnings Date May 13, 2025

About Cipla

Cipla Limited, together with its subsidiaries, engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer’s disease, hypertension, arrhythmia, lipid abnormaliti... [Read more]

Industry Pharmaceutical Preparations
Founded 1935
Employees 27,764
Stock Exchange Luxembourg Stock Exchange
Ticker Symbol CIPLA
Full Company Profile

Financial Performance

In 2024, Cipla's revenue was 271.45 billion, an increase of 6.30% compared to the previous year's 255.37 billion. Earnings were 52.73 billion, an increase of 27.93%.

Financial numbers in INR Financial Statements

News

There is no news available yet.